Pfizer and BioNTech Announce Data from Preclinical Studies of mRNA-based Vaccine Candidate Against…
Pfizer Inc. and BioNTech SE announced preliminary preclinical data in mouse and non-human primate models from their BNT162b2 mRNA-based vaccine program against SARS-CoV-2, the virus…
Read More...
Read More...
